DE60104421D1 - Prochelators von radiometall markierten molekülen - Google Patents

Prochelators von radiometall markierten molekülen

Info

Publication number
DE60104421D1
DE60104421D1 DE60104421T DE60104421T DE60104421D1 DE 60104421 D1 DE60104421 D1 DE 60104421D1 DE 60104421 T DE60104421 T DE 60104421T DE 60104421 T DE60104421 T DE 60104421T DE 60104421 D1 DE60104421 D1 DE 60104421D1
Authority
DE
Germany
Prior art keywords
sub
radiometally
prochelators
formula
radiometal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60104421T
Other languages
English (en)
Other versions
DE60104421T2 (de
Inventor
R Maecke
Klaus Eisenwiener
Pia Powell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Hospital Basel Ch
Original Assignee
Universitaetsspital Basel USB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8168693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60104421(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Universitaetsspital Basel USB filed Critical Universitaetsspital Basel USB
Application granted granted Critical
Publication of DE60104421D1 publication Critical patent/DE60104421D1/de
Publication of DE60104421T2 publication Critical patent/DE60104421T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
DE60104421T 2000-05-12 2001-05-11 Prochelators von radiometall markierten molekülen Expired - Lifetime DE60104421T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00110084 2000-05-12
EP00110084 2000-05-12
PCT/EP2001/005483 WO2002024235A2 (en) 2000-05-12 2001-05-11 Prochelators of radiometal labeled molecules

Publications (2)

Publication Number Publication Date
DE60104421D1 true DE60104421D1 (de) 2004-08-26
DE60104421T2 DE60104421T2 (de) 2005-09-22

Family

ID=8168693

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60104421T Expired - Lifetime DE60104421T2 (de) 2000-05-12 2001-05-11 Prochelators von radiometall markierten molekülen

Country Status (8)

Country Link
US (1) US20060233704A1 (de)
EP (1) EP1289571B1 (de)
JP (1) JP2004509152A (de)
AT (1) ATE271396T1 (de)
AU (2) AU2001277488B2 (de)
DE (1) DE60104421T2 (de)
ES (1) ES2221903T3 (de)
WO (1) WO2002024235A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2312983T3 (es) * 2003-03-19 2009-03-01 Universitatsspital Basel Conjugados radiomarcados basados en sustancia p y sus usos.
US20060155120A1 (en) * 2003-05-23 2006-07-13 Amedio John C Optically pure and enriched isomers of chelating ligands and contrast agents
US8986650B2 (en) 2005-10-07 2015-03-24 Guerbet Complex folate-NOTA-Ga68
US8926945B2 (en) 2005-10-07 2015-01-06 Guerbet Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
US8193347B2 (en) * 2006-03-14 2012-06-05 Mallinckrodt Llc Metal complexes of tetraazamacrocycle derivatives
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
CN101516899B (zh) * 2006-04-19 2016-07-06 得克萨斯大学体系董事会 细胞成像和治疗的组合物和方法
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
CN102272109A (zh) * 2008-11-11 2011-12-07 南洋理工大学 血管内造影剂
US9056841B2 (en) 2009-03-19 2015-06-16 The Johns Hopkins University PSMA-targeting compounds and uses thereof
FR2959502B1 (fr) * 2010-04-30 2012-09-07 Nanoh Nanoparticules ultrafines a matrice polyorganosiloxane fonctionnalisee et incluant des complexes metalliques ; leur procede d'obtention et leurs applications en imagerie medicale et/ou therapie
RU2457215C1 (ru) * 2011-04-07 2012-07-27 Закрытое Акционерное Общество "Фарм-Синтез" Октапептид для получения радиофармацевтических средств, радиофармацевтическое средство на его основе и способ диагностики опухолей, экспрессирующих соматостатиновые рецепторы
KR101855509B1 (ko) * 2015-11-12 2018-05-09 한국원자력연구원 방사성 의약품의 제조를 위한 바이알 키트 및 이를 이용한 방사성 의약품의 제조 방법
CN117603148A (zh) 2017-05-05 2024-02-27 探针技术开发及商业化中心 双官能螯合物的药代动力学增强及其用途
RU2019139434A (ru) 2017-05-05 2021-06-07 Сентр фор Проуб Девелопмент энд Коммерсиализэйшн Моноклональные антитела против igf-1r и их применение
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
US20240207463A1 (en) * 2021-03-31 2024-06-27 Nihon Medi-Physics Co., Ltd. Radioactive complex of anti-egfr antibody, and radiopharmaceutical
DE102021109246B3 (de) 2021-04-13 2022-06-09 ITM Isotope Technologies Munich SE Radiopharmaka zu unterschiedlichen ARTs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW213864B (de) * 1991-08-01 1993-10-01 Squibb & Sons Inc

Also Published As

Publication number Publication date
US20060233704A1 (en) 2006-10-19
AU7748801A (en) 2002-04-02
EP1289571B1 (de) 2004-07-21
WO2002024235A2 (en) 2002-03-28
EP1289571A2 (de) 2003-03-12
ES2221903T3 (es) 2005-01-16
AU2001277488B2 (en) 2006-05-18
DE60104421T2 (de) 2005-09-22
ATE271396T1 (de) 2004-08-15
JP2004509152A (ja) 2004-03-25
WO2002024235A3 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
DE60104421D1 (de) Prochelators von radiometall markierten molekülen
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
BR9808491A (pt) Compostos calcilìticos
RS51635B (sr) Antitela koja blokiraju cripto i njihova upotreba
EA200000048A1 (ru) ИНГИБИТОРЫ ФАКТОРА Ха, СОДЕРЖАЩИЕ ГРУППУ С НЕЙТРАЛЬНОЙ P1-СПЕЦИФИЧНОСТЬЮ
PT766678E (pt) Agentes clarificantes opticos
BR9509665A (pt) Composto composições e métodos
IT1270882B (it) Oligopeptidi ad attivita' fungicida
NO995906D0 (no) Radioprotektant for peptider merket med radioisotop
ATE178053T1 (de) N2s2-chelatoren des hydrazino-typs
DE69830492D1 (de) Antikörper als ARZNEIMITTEL GEGEN LYMPHOCYTISCHE TUMORE (AUSSCHLIESSLICH MYELOME)
AU7949391A (en) Kit for the specific assay of angiotensin ii
DE69434384D1 (de) Metalkomplexbildner
IT1293778B1 (it) 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli
EP2962699A3 (de) Verbessertes verfahren zur herstellung von konjugaten von proteinen und chelatbildnern
NO971621L (no) Keratinocyttvekstfaktoranaloger
ATE356831T1 (de) Neuer galaninrezeptor
DK1279677T3 (da) GD3-mimetiske peptider
DK1127064T3 (da) Hidtil ukendte aminosyresekvenser, DNA, der koder for aminosyresekvenserme, antistoffer, der er rettet mod sådanne sekvenser, og forskellige anvendelser deraf
DK0871612T3 (da) Kondenserede isoindoloner som proteinkinase C-inhibitorer
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
DK0994121T3 (da) Forgrenede peptider i analyser for antistoffer
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
EA199900710A1 (ru) Кристаллическая гидратированная натриевая соль (е)-4,6-дихлор-3-(2-оксо-1-фенилпирролидин-3-илиденметил)-1н-индол-2-карбоновой кислоты
ES2160491A1 (es) Secuencia aminoacida apta para afectar la actividad enzimatica de pectin metilesterasas (pme) y secuencia nucleotica para enzimas que afectan petin metilesterasas comprendiendo dicha secuencia aminoacida.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: UNIVERSITY HOSPITAL, BASEL, CH

8364 No opposition during term of opposition